NCT07772349

Brief Summary

The aim of the study is to assess the treatment effects of deep active repetitive transcranial magnetic stimulation (rTMS) with H4 coil combined with cognitive training for improving frontal white matter microstructural integrity in patients with schizophrenia spectrum disorder (SSD).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P75+ for not_applicable schizophrenia

Timeline
31mo left

Started Oct 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 19, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2029

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2029

Last Updated

August 19, 2026

Status Verified

August 1, 2026

Enrollment Period

2.6 years

First QC Date

August 13, 2026

Last Update Submit

August 13, 2026

Conditions

Keywords

Transcranial magnetic stimulationschizophreniawhite matterconnectivitymyelination

Outcome Measures

Primary Outcomes (2)

  • Brain microstructural integrity as indicated by white matter fractional anisotropy (FA) values as assessed by magnetic resonance imaging (MRI)

    Fractional anisotropy (FA) values will be reported. FA values range from 0 to 1 with larger values indicating greater white matter integrity.

    baseline, visit 6 (about 1 week after baseline), visit 10 (about 2 weeks after baseline)

  • Brain connectivity as indicated by resting-state functional connectivity (rsFC) values as assessed by functional MRI (fMRI)

    rsFC values will be reported as a Z-score with a range of -1 to 1, with greater absolute values indicating stronger brain connectivity.

    baseline, visit 6 (about 1 week after baseline), visit 10 (about 2 weeks after baseline)

Secondary Outcomes (14)

  • Electrophysiological response as indicated by mismatch negativity as assessed by electroencephalography (EEG)

    baseline, visit 6 (about 1 week after baseline), visit 10 (about 2 weeks after baseline)

  • Electrophysiological response as indicated by steady-state auditory evoked responses from electroencephalography recording (EEG)

    baseline, visit 6 (about 1 week after baseline), visit 10 (about 2 weeks after baseline)

  • Cognitive insight as assessed by the Beck Cognitive Insight Scale

    baseline, visit 6 (about 1 week after baseline), visit 10 (about 2 weeks after baseline)

  • Emotion regulation as assessed by the Profile of Mood States (POMS)

    day 1 after baseline, day 2 after baseline, day 3 after baseline, day 4 after baseline, day 5 after baseline, day 9 after baseline, day 10 after baseline,

  • Depression as assessed by the Depression State and Trait Scale (DST) - state

    baseline, visit 6 (about 1 week after baseline), visit 10 (about 2 weeks after baseline)

  • +9 more secondary outcomes

Study Arms (4)

Active rTMS Combined with Strong Cognitive Training

EXPERIMENTAL

Participants will receive active H-coil delivered rTMS, as well as strong cognitive training in each treatment visit for up to 10 treatment visits within about 2 weeks. In each visit, there are three rTMS sessions and each of them is followed by a cognitive training session and a rest period, which allows the inter-rTMS-session interval to be about 30 minutes. The cognitive training includes several cognitive computer games that are meant to improve the speed and accuracy of performance--strong cognitive training is intended to significantly enhance cognitive functions.

Device: Active rTMSBehavioral: Strong Cognitive Training

Active rTMS Combined with Weak Cognitive Training

EXPERIMENTAL

Participants will receive active H-coil delivered rTMS, as well as weak cognitive training in each treatment visit for up to 10 treatment visits within about 2 weeks. In each visit, there are three rTMS sessions and each of them is followed by a cognitive training session and a rest period, which allows the inter-rTMS-session interval to be about 30 minutes. The cognitive training includes several cognitive computer games that are meant to improve the speed and accuracy of performance--weak cognitive training may yield only modest improvements in cognitive functions.

Device: Active rTMSBehavioral: Weak Cognitive Training

Sham rTMS Combined with Strong Cognitive Training

EXPERIMENTAL

Participants will receive sham H-coil delivered rTMS, as well as strong cognitive training in each treatment visit for up to 10 treatment visits within about 2 weeks. In each visit, there are three rTMS sessions and each of them is followed by a cognitive training session and a rest period, which allows the inter-rTMS-session interval to be about 30 minutes. In case of sham TMS, no actual magnetic stimulation will occur, still the participant hears the TMS sound and a skin sensation. The cognitive training includes several cognitive computer games that are meant to improve the speed and accuracy of performance--strong cognitive training is intended to significantly enhance cognitive functions.

Behavioral: Strong Cognitive TrainingDevice: Sham rTMS

Sham rTMS Combined with Weak Cognitive Training

EXPERIMENTAL

Participants will receive sham H-coil delivered rTMS, as well as weak cognitive training in each treatment visit for up to 10 treatment visits within about 2 weeks. In each visit, there are three rTMS sessions and each of them is followed by a cognitive training session and a rest period, which allows the inter-rTMS-session interval to be about 30 minutes. In case of sham TMS, no actual magnetic stimulation will occur, still the participant hears the TMS sound and a skin sensation. The cognitive training includes several cognitive computer games that are meant to improve the speed and accuracy of performance--weak cognitive training may yield only modest improvements in cognitive functions.

Device: Sham rTMSBehavioral: Weak Cognitive Training

Interventions

Active H-coil delivered rTMS sessions will be given three times per treatment visit for up to 10 visits within about 2 weeks. There are about 30 minutes breaks between adjacent TMS sessions. Each TMS session takes about 3 to 4 minutes to complete.

Active rTMS Combined with Strong Cognitive TrainingActive rTMS Combined with Weak Cognitive Training

For the cognitive training sessions, patients will be asked to play cognitive computer games involving processing speed tasks for about 15 to 30 minutes. Strong cognitive training is intended to significantly enhance cognitive functions

Active rTMS Combined with Strong Cognitive TrainingSham rTMS Combined with Strong Cognitive Training
Sham rTMSDEVICE

Sham H-coil delivered rTMS sessions will be given three times per treatment visit for up to 10 visits within about 2 weeks. There are about 30 minutes breaks between adjacent TMS sessions. Each TMS session takes about 3 to 4 minutes to complete. In case of sham TMS, no actual magnetic stimulation will occur, still the participant hears the TMS sound and a skin sensation.

Sham rTMS Combined with Strong Cognitive TrainingSham rTMS Combined with Weak Cognitive Training

For the cognitive training sessions, patients will be asked to play cognitive computer games involving processing speed tasks for about 15 to 30 minutes. Weak cognitive training may yield only modest improvements in cognitive functions.

Active rTMS Combined with Weak Cognitive TrainingSham rTMS Combined with Weak Cognitive Training

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female ages between ages 18-60 years
  • Ability to give written informed consent (age 18 or above)
  • Diagnosed with schizophrenia-spectrum disorder and Evaluation to Sign Consent (ESC) above 10.

You may not qualify if:

  • Inability to sign informed consent.
  • Any history of seizures.
  • Taking \> 400 mg clozapine/day and not on anti-seizure medication(s) with sufficient dose.
  • Failed TMS screening questionnaire.
  • Significant alcohol or other drug use (substance abuse within 1 month or substance dependence history within 6 months and having substance usage within 1 month) other than nicotine or marijuana dependence.
  • A history of thrombosis, family history of thrombosis, or medical conditions that may lead to a hypercoagulable state (increased chance to develop blood clots)
  • Woman who is pregnant (child-bearing potential but not on contraceptive and missing menstrual period; or by self-report; or by positive urine pregnancy test).
  • History of head injury with loss of consciousness over 10 minutes; history of brain surgery
  • Cannot refrain from using alcohol and/or marijuana 24 hours or more prior to experiments.
  • Students and employees currently involved with our lab (lab employees and personnel will be excluded from the study to avoid possible coercion or possible appearance of coercion, or chance of breach of privacy and confidentiality).
  • For MRI, unable to undergo MRI scanning due to metallic devices or objects (cardiac pacemaker or neurostimulator, some artificial joints, metal pins, surgical clips, or other implanted metal parts) or claustrophobic to the scanner.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center, Houston

Houston, Texas, 77054, United States

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Xiaoming Du, PhD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 13, 2026

First Posted

August 19, 2026

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

May 1, 2029

Last Updated

August 19, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations